Delayed neuroprotection against cerebral ischemia reperfusion injury: putative role of BDNF and GSK-3β
Authors:
- 9 June 2015
- journal article
- research article
- Published by Taylor & Francis in Journal of Receptors and Signal Transduction
- Vol. 36 (4) , 402-410
Abstract
Aim: Numerous studies have demonstrated the possible neuroprotective role of lithium treatment against neurological disorders. However, the role of lithium in delayed phase of neuronal death against focal ischemia has not been explored. Therefore, the present study was designed to investigate the effect and molecular mechanisms of post-lithium treatment against cerebral ischemic reperfusion (I/R) injury and associated cognitive deficits in rats. Methods: I/R injury was induced by right middle cerebral artery occlusion and lithium (40 and 60 mg/kg) were given intraperitoneally, 24 h after the insult and continued for 1 week with 24-h interval. Using Lasser Doppler, cerebral blood flow was monitored before, during and after MCAO induction. Besides behavioral, biochemical, and histological evaluation, levels of tumor necrosis factor alpha (TNF-α) and brain-derived neurotrophic factor (BDNF) were also estimated. Results: I/R injury resulted in significant elevation of neurological deficits, oxidative stress, neuroinflammation, and cognitive impairments. We found that lithium injection, 24 h after I/R-injury continued for 1 week, dose dependently prevented behavioral abnormality and cognitive impairments. Moreover, lithium attenuated the levels of oxidative stress and pro-inflammatory-cytokines TNF-α level. Further, lithium treatments significantly reduced neuronal damage and augmented healthy neuronal count and improved neuronal density in hippocampus. These neuroprotective effects of delayed lithium treatment were associated with upregulation of neurotrophic factor BDNF levels. Conclusion: Delayed lithium treatment provides neuroprotection against cerebral I/R injury and associated cognitive deficits by upregulating BDNF expression that opens a new avenue to treat I/R injury even after active cell death.Keywords
This publication has 43 references indexed in Scilit:
- Ischemia-Reperfusion Injury in StrokeInterventional Neurology, 2012
- Beneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke modelsActa Pharmacologica Sinica, 2011
- Lithium-Mediated Long-Term Neuroprotection in Neonatal Rat Hypoxia–Ischemia is Associated with Antiinflammatory Effects and Enhanced Proliferation and Survival of Neural Stem/Progenitor CellsJournal of Cerebral Blood Flow & Metabolism, 2011
- GSK-3 Inhibitors: Preclinical and Clinical Focus on CNSFrontiers in Molecular Neuroscience, 2011
- GSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic StrokeFrontiers in Molecular Neuroscience, 2011
- Valproic Acid Attenuates Blood–Brain Barrier Disruption in a Rat Model of Transient Focal Cerebral Ischemia: The Roles of HDAC and MMP-9 InhibitionJournal of Cerebral Blood Flow & Metabolism, 2010
- Early Motor Balance and Coordination Training Increased Synaptophysin in Subcortical Regions of the Ischemic Rat BrainJournal of Korean Medical Science, 2010
- TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative diseaseJournal of Neuroinflammation, 2008
- Chronic Treatment With a Low Dose of Lithium Protects the Brain Against Ischemic Injury by Reducing Apoptotic DeathStroke, 2003
- Cognitive Deficits After Focal Cerebral Ischemia in MiceStroke, 2000